ICCC Stock Analysis: Buy, Sell, or Hold?
ICCC - Immucell Corp
$6.02
-0.02 (-0.33%)
▼
BUY
HIGH Confidence
Last Updated: January 30, 2026
Earnings: Feb 25, 2026
24d
Get Alerted When ICCC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: ICCC shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
✅ BUY SIGNAL: ICCC shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
In-depth Analysis How we analyze
Valuation Analysis: ICCC is currently trading at $6.02, which is considered oversold relative to its 30-day fair value range of $6.06 to $6.57.
Technical Outlook: Technically, ICCC is showing sideways momentum. The price is currently testing key support at $6.00. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $14.00 (+131.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ICCC is showing sideways momentum. The price is currently testing key support at $6.00. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $14.00 (+131.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$6.06 -
$6.57
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 131.8% below Wall St target ($14.00)
Fair Price Analysis
30-Day Fair Range
$6.06 -
$6.57
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$6.00
Resistance Level
$6.92
Current Trend
Sideways
Fundamental Context
Wall Street Target
$14.00
(+131.8%)
Revenue Growth (YoY)
17.8%
Earnings Growth (YoY)
-63.4%
Profit Margin
6.2%
Last updated: January 31, 2026 7:41 AM ET
Data refreshes hourly during market hours. Next update: 8:41 AM
Data refreshes hourly during market hours. Next update: 8:41 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ICCC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$66 | 46 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$112 | 52 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$90 | 59 HOLD |
|
RNA
Avidity Biosciences Inc |
STRONG BUY
15 analysts |
$75 | 62 BUY |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$35 | 51 HOLD |
Advanced ICCC Option Strategies
Professional options setups generated by AI based on today's ICCC price and gamma walls.
